Craneware plc (LON:CRW - Get Free Report)'s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 2,228.05 ($27.92) and traded as high as GBX 2,243 ($28.11). Craneware shares last traded at GBX 2,201.69 ($27.59), with a volume of 18,617 shares trading hands.
Analyst Ratings Changes
Several equities research analysts have issued reports on the stock. Shore Capital reiterated a "buy" rating on shares of Craneware in a research note on Tuesday, December 10th. Berenberg Bank reiterated a "buy" rating and set a GBX 2,700 ($33.83) target price on shares of Craneware in a report on Tuesday, September 3rd.
View Our Latest Analysis on CRW
Craneware Trading Down 0.8 %
The company has a market cap of £778.08 million, a price-to-earnings ratio of 8,468.05 and a beta of 0.28. The firm has a fifty day moving average price of GBX 2,166.10 and a 200 day moving average price of GBX 2,227.87. The company has a debt-to-equity ratio of 12.22, a quick ratio of 1.00 and a current ratio of 0.63.
About Craneware
(
Get Free Report)
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.
Featured Stories
Before you consider Craneware, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.
While Craneware currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
